Clinical Consulting

20+ years of Supporting Life Sciences

With the estimated cost of bringing a drug to market at $2.5 billion and the probability of success of getting to the market from phase 1 at less than 10%, clinical operations have never faced a more challenging environment than now.

While a typical phase 3 trial generates 900,000 data points, many companies still rely on Excel spreadsheets to bring data together from traditionally silo-ed sources. This takes time which limits the ability to drive decisions off clinical data in real time.

Monitoring services predominantly rely on routinely scheduled site visits to verify source data, resulting in high travel costs, and inefficient processes. 100% source data verification accounts for up to 25% of trial costs. However, it does not contribute to data quality value, instead alternative, risk based, approaches can benefit patient safety without such a significant cost contribution.

Inspection findings reflect this complex picture, with critical findings from EMA, MHRA and FDA focused on the following areas:

  • Data capture, clean-up, analysis, integrity and management
  • Risk based monitoring
  • Sponsor trial management and CRO oversight
  • TMF, QMS and essential document management

Reflecting these findings, the ICH GCP guidelines have been revised in 2017, thereby adding a further compliance challenge for clinical operations.

Top-level Clinical Strategy Challenges

  • Patient-Centric
    Outcomes

    patient-centric

    Making the clinical trial
    recruitment process robust, and compliant for the sponsor whilst being easy for the patients

  • Operational
    Efficiency

    operational-efficiency

    Addressing silo-ed
    data sources, eliminating inefficient processes, reducing source data verification

  • Innovation &
    Transformation

    innovation

    Adapting to risk
    based and adaptive
    monitoring

  • Quality &
    Compliance

    high-quality-output

    Optimizing processes
    while maintaining
    or improving compliance

Navitas Life Sciences Creates Impactful Results for Sponsors Through an Integrated Approach

Our global clinical consultants apply their extensive expertise and knowledge to guide sponsors to achieve their strategic objectives through best practices. With over 20 years of experience of supporting Life Sciences companies, breakthrough insights gained through our industry network forums, models for success, and proven structured approaches, Navitas Life Sciences serves as a trusted strategic advisor.

Trusted Strategic Advisor

  • global-team-of-consultants

    Global Team of Consultants

  • insights-through-proprietary

    Insights through Proprietary Industry Networks

  • proven-models-for-success

    Proven Models for Success

  • structured-approaches

    Structured Approaches

Our breadth and depth of experience has taught us that there is no one-size-fits-all solution. We take a personalized approach to each client situation to ensure results are grounded in industry best-practices, but tailored to specific needs, fit-for-purpose, cost-effective, scalable, and compliant. Engagements begin with a detailed current state assessment to prioritize improvement opportunities and continue beyond pragmatic recommendations to include detailed solution design and implementation. This includes managing the change, developing / revising controlled documents, incorporating revised responsibilities into role descriptions, and developing training plans and materials for roll-out across functional stakeholders.

By including our clients’ subject matter experts, who have deep institutional knowledge, prominently on project teams, improvements are implemented smoothly to ensure project benefits continue to be realized beyond the end of our contractual engagement.

  • Patient-Centric
    Outcomes

    patient-centric

    Support for
    site-less trials

  • Operational
    Efficiency

    operational-efficiency

    Data
    unification

  • Innovation &
    Transformation

    innovation

    Transformation to Risk Based Monitoring

  • Quality &
    Compliance

    high-quality-output

    ICH E6 GCP Health check, Support for Inspection Readiness

Our Clinical Consulting Services Include

  • All
  • AMS
  • BI
  • Brochure
  • CaseStudy
  • Clinical
  • CMS
  • MedicalDevices
  • On DemandWebinar
  • Quality
  • Regulatory
  • Safety
  • Technology
  • Whitepaper

Latest News

01
Dec2017

Navitas brings End – to – End R D Solutions to the Generic Drug Industry

Navitas Life Sciences, a TAKE Solutions Enterprise, provides services and technology to deliver “first...